March 13, 2023
Shionogi has issued the latest side effect update on its oral COVID-19 treatment Xocova (ensitrelvir), revealing that the number of serious adverse events now totals eight, reported from eight patients. According to the seventh Xocova post-marketing surveillance update, the drug...read more